Indoor Harvest Acquires Majority Control In Metabiogenix USA

Indoor Harvest Corp. INQD announced the acquisition of a 60% controlling interest in Metabiogenix USA for $2.5 million in a combination of cash and common stock. During the close of the acquisition, Metabiogenix USA received a valuation of $8.9 million from the Japanese Medical Institute.

“This acquisition will provide Indoor Harvest an exclusive agreement to market and distribute the portfolio of Metabiogenix USA Nutraceuticals throughout the entire Western Hemisphere (North, South, and Central America), and Spain. Metabiogenix USA is on track for substantial growth and projecting revenues that could be as high as $20 million for FY2024” stated Leslie Bocskor, chairman & CEO of INQD. “Words cannot express the gratitude I am experiencing to have Dr. Mario Acosta Mejia join Indoor Harvest and look forward to working with him to develop this paradigm shifting class of health and wellness products as he continues to lead Metabiogenix USA.”

With the evolution of wellness and health technologies built from the foundation of probiotics, a new generation of metabiotics has been developed by the Japanese Medical Institute to work towards improving the life expectancy and quality of life to people around the world. Japan currently has the longest life expectancy with the average lifespan of 87 years. Dr. Acosta, co-founder and president of Metabiogenix USA, was among the original principal clinical investigators at the Japanese Medical Institute and was instrumental in developing Metabiox.

“After years of working with my counterparts in Japan, Mexico, and Europe to develop this new class of health and wellness products, we will continue to revolutionize preventative methods around the world by bringing education and tools to doctors and medical practitioners as these patented products continue to evolve,” stated Dr. Acosta. “I am honored to join the Indoor Harvest family and looking forward to leading Metabiogenix USA and educating the world about “The Metabolism of Life!”.

As part of the acquisition, Dr. Acosta will be retained under a new developing employment agreement as president of Metabiogenix USA.

Photo: Benzinga edit with photos by jarmoluk and lindsayfox on Pixabay

Related News

Indoor Harvest Corp. Acquires 369Hemp, Plans To Expand Into Smokable Hemp Market

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsJapanese Medical InstituteLeslie BocskorMario Acosta MejiaMetabiogenix USApremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...